Higher glucagon-to-insulin ratio is associated with elevated glycated hemoglobin levels in type 2 diabetes patients
Minyoung Lee, Minkyung Kim, Jong Suk Park, Sangbae Lee, Jihong You, Chul Woo Ahn, Kyung Rae Kim, Shinae Kang
Korean J Intern Med. 2019;34(5):1068-1077.   Published online 2017 Sep 8     DOI: https://doi.org/10.3904/kjim.2016.233
Citations to this article as recorded by Crossref logo
Lowest Glucagon/Highest C-Peptide in Oral Glucose Tolerance Test: Clinical Utility in Monitoring Glucose Control in Type 2 Diabetes Mellitus
Lina Chang, Xiaohui Ma, Menghua Yuan, Li Ding, Yian Gu, Lili Liu, Yan Li, Hua Shu, Ming Liu, Qing He
Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 1769.     CrossRef
Mesenchymal stromal cells ameliorate mitochondrial dysfunction in α cells and hyperglucagonemia in type 2 diabetes via SIRT1/FoxO3a signaling
Jia Song, Lingshu Wang, Liming Wang, Xinghong Guo, Qin He, Chen Cui, Huiqing Hu, Nan Zang, Mengmeng Yang, Fei Yan, Kai Liang, Chuan Wang, Fuqiang Liu, Yujing Sun, Zheng Sun, Hong Lai, Xinguo Hou, Li Chen
Stem Cells Translational Medicine.2024; 13(8): 776.     CrossRef
Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus
Jan Bures, Darina Kohoutova, Jan Skrha, Bohus Bunganic, Ondrej Ngo, Stepan Suchanek, Pavel Skrha, Miroslav Zavoral
Cancers.2023; 15(14): 3669.     CrossRef
Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes
Jisun Bang, Sang Ah Lee, Gwanpyo Koh, Soyeon Yoo
Journal of Clinical Medicine.2023; 12(18): 5806.     CrossRef
Follistatin and follistatin-like 3 in metabolic disorders
Weronika Bielka, Agnieszka Przezak, Andrzej Pawlik
Prostaglandins & Other Lipid Mediators.2023; 169: 106785.     CrossRef
Regulation of Macronutrients in Insulin Resistance and Glucose Homeostasis during Type 2 Diabetes Mellitus
Wanbao Yang, Wen Jiang, Shaodong Guo
Nutrients.2023; 15(21): 4671.     CrossRef
Voluntary physical activity protects against olanzapine-induced hyperglycemia
Hesham Shamshoum, Greg L. McKie, Kyle D. Medak, Kristen E. Ashworth, Bruce E. Kemp, David C. Wright
Journal of Applied Physiology.2021; 130(2): 466.     CrossRef
VIP reduction in the pancreas of F508del homozygous CF mice and early signs of Cystic Fibrosis Related Diabetes (CFRD)
Anna Semaniakou, Frederic Chappe, Younes Anini, Valerie Chappe
Journal of Cystic Fibrosis.2021; 20(5): 881.     CrossRef
The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
Soyeon Yoo, Dongkyu Kim, Gwanpyo Koh
Journal of Clinical Medicine.2021; 10(11): 2487.     CrossRef
Functional Status of Pancreatic α and β Cells in Type 2 Diabetes Mellitus Patients with Different Plasma Triglyceride Levels: A Retrospective Analysis
Hang Guo, Chunlei Ma, Xiaoming Wu, Congqing Pan, Reinhard Depping
International Journal of Endocrinology.2021; 2021: 1.     CrossRef
Bihormonal dysregulation of insulin and glucagon contributes to glucose intolerance development at one year post-delivery in women with gestational diabetes: a prospective cohort study using an early postpartum 75-g glucose tolerance test
Riyoko Shigeno, Ichiro Horie, Masaki Miwa, Ayako Ito, Ai Haraguchi, Shoko Natsuda, Satoru Akazawa, Ai Nagata, Yuri Hasegawa, Shoko Miura, Kiyonori Miura, Atsushi Kawakami, Norio Abiru
Endocrine Journal.2021; 68(8): 919.     CrossRef
Mesenchymal stem cell-conditioned medium alleviates high fat-induced hyperglucagonemia via miR-181a-5p and its target PTEN/AKT signaling
Jia Song, Qin He, Xinghong Guo, Lingshu Wang, Jinbang Wang, Chen Cui, Huiqing Hu, Mengmeng Yang, Yixin Cui, Nan Zang, Fei Yan, Fuqiang Liu, Yujing Sun, Kai Liang, Jun Qin, Ruxing Zhao, Chuan Wang, Zheng Sun, Xinguo Hou, Wenjuan Li, Li Chen
Molecular and Cellular Endocrinology.2021; 537: 111445.     CrossRef
Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression
Yuying Wang, Zhiqi Lin, Heng Wan, Wen Zhang, Fangzhen Xia, Yi Chen, Xiaoman Chen, Chiyu Wang, Chi Chen, Ningjian Wang, Yingli Lu
European Journal of Gastroenterology & Hepatology.2021; 33(1S): e818.     CrossRef
Postprandial Lipemia Modulates Pancreatic Alpha-Cell Function in the Prediction of Type 2 Diabetes Development: The CORDIOPREV Study
Isabel Pozuelo-Sanchez, Alejandro Villasanta-Gonzalez, Juan Francisco Alcala-Diaz, Cristina Vals-Delgado, Ana Leon-Acuña, Anabel Gonzalez-Requero, Elena Maria Yubero-Serrano, Raul Miguel Luque, Javier Caballero-Villarraso, Ivan Quesada, José María Ordovas
Journal of Agricultural and Food Chemistry.2020; 68(5): 1266.     CrossRef
Effect of Momordica charantia on Glucagon Secretion in High-fat diet(HFD)/Streptozotocin(STZ)-induced Diabetic Rat
Seong-Eun Kim, Sang-Back Kim, Seul Ki Kim, Hyun-Kyu Kim, Byoungjun Park, Hak Sung Lee
Journal of Environmental Science International.2020; 29(8): 837.     CrossRef
GLP1 receptor agonism protects against acute olanzapine-induced hyperglycemia
Kyle D. Medak, Hesham Shamshoum, Willem T. Peppler, David C. Wright
American Journal of Physiology-Endocrinology and Metabolism.2020; 319(6): E1101.     CrossRef
Glucagon Levels During Short-Term SGLT2 Inhibition Are Largely Regulated by Glucose Changes in Patients With Type 2 Diabetes
Per Lundkvist, Maria J Pereira, Prasad G Kamble, Petros Katsogiannos, Anna Maria Langkilde, Russell Esterline, Eva Johnsson, Jan W Eriksson
The Journal of Clinical Endocrinology & Metabolism.2019; 104(1): 193.     CrossRef